NDC 68071-3178-00 - LISINOPRIL

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
68071-3178
Requested NDC
68071-3178-00
Package NDCs from labels
68071-3178-3, 68071-3178-5, 68071-3178-6, 68071-3178-9, 68071-3178-2, 68071-3178-0, 68071-3178-00
Manufacturer
NuCare Pharmaceuticals, Inc.
Effective date
2026-06-11
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
LISINOPRIL - NuCare Pharmaceuticals, Inc.NuCare Pharmaceuticals, Inc.2026-06-11HUMAN PRESCRIPTION DRUG LABEL

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDCEffectiveRelated label
68071-3178-22024-07-19These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988
68071-3178-22024-07-19These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988
68071-3178-32024-07-19These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988
68071-3178-32024-07-19These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988
68071-3178-52024-07-19These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988
68071-3178-52024-07-19These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988
68071-3178-62024-07-19These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988
68071-3178-62024-07-19These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988
68071-3178-92024-07-19These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988
68071-3178-92024-07-19These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988
68071-3178-22023-01-30These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988
68071-3178-22023-01-30These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988
68071-3178-32023-01-30These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988
68071-3178-32023-01-30These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988
68071-3178-52023-01-30These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988
68071-3178-52023-01-30These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988
68071-3178-62023-01-30These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988
68071-3178-62023-01-30These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988
68071-3178-92023-01-30These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988
68071-3178-92023-01-30These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988
68071-3178-22021-02-11These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988
68071-3178-22021-02-11These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988
68071-3178-32021-02-11These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988
68071-3178-32021-02-11These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988
68071-3178-52021-02-11These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988
68071-3178-52021-02-11These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988
68071-3178-62021-02-11These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988
68071-3178-62021-02-11These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988
68071-3178-92021-02-11These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988
68071-3178-92021-02-11These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988
68071-3178-22021-01-29These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988
68071-3178-22021-01-29These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988
68071-3178-32021-01-29These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988
68071-3178-32021-01-29These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988
68071-3178-52021-01-29These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988
68071-3178-52021-01-29These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988
68071-3178-62021-01-29These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988
68071-3178-62021-01-29These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988
68071-3178-92021-01-29These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988
68071-3178-92021-01-29These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
68071-3178-2LISINOPRIL120 in 1 BOTTLETABLET1205
68071-3178-3LISINOPRIL30 in 1 BOTTLETABLET305
68071-3178-5LISINOPRIL45 in 1 BOTTLETABLET455
68071-3178-6LISINOPRIL60 in 1 BOTTLETABLET605
68071-3178-9LISINOPRIL90 in 1 BOTTLETABLET905

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
68071-3178LISINOPRIL TABLET [NUCARE PHARMACEUTICALS, INC.]5Current NDC, Legacy NDC, 5 package rows20240720_4b6dc0d4-4acd-3606-e054-00144ff8d46c.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 44 · 867 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LISINOPRILLISINOPRILPD-Rx Pharmaceuticals, Inc.bf59ff89-a9fa-4fe3-b167-a5d0cba9e4382026-11-05Boxed warning, Warnings, Adverse reactionsExact identifier
application number: ANDA076164
rxcui: 311354
unii: E7199S1YWR
Calamine PlusCALAMINE PLUS PRAMOXINE HCLAmerisourceBergen Drug Corporationf161e151-4fab-2fbc-e053-2a95a90a54372026-11-04WarningsExact identifier
unii: 1K09F3G675
Calamine Plus Pramoxine HClCALAMINE PLUS SPRAYHY-VEE, INC415ecfe9-3145-f23e-e063-6394a90adfd82026-11-04WarningsExact identifier
unii: 1K09F3G675
Calamine PlusCALAMINE PLUS PRAMOXINE HCLMeijer Distribution Inc.03c46823-0b1f-4101-e063-6294a90aaf942026-11-04WarningsExact identifier
unii: 1K09F3G675
Calamine Plus Pramoxine HClCALAMINE PLUS NO TOUCH SPRAYPremier Brands of America Inc.36481d67-2346-470b-e063-6294a90aae992026-11-04WarningsExact identifier
unii: 1K09F3G675
Calamine PlusCALAMINE PLUS PRAMOXINE HCLChain Drug Marketing Association Inc1a3f8819-58cf-8923-e063-6394a90a37af2026-11-04WarningsExact identifier
unii: 1K09F3G675
Lisinopril and HydrochlorothiazideLISINOPRIL AND HYDROCHLOROTHIAZIDECoupler LLC5f4e3bc8-2810-f1ae-e063-6394a90a97252026-11-02Boxed warning, Warnings, Adverse reactionsExact identifier
unii: E7199S1YWR
MannitolMANNITOLHenry Schein, Inc.e2444db1-9dfe-451f-a33c-9b00786464d22026-11-02Warnings, Adverse reactionsExact identifier
unii: 3OWL53L36A
LisinoprilLISINOPRILREMEDYREPACK INC.aa5d68e7-c2b9-41eb-ade4-2cd57edc15332026-10-28Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 314076
unii: E7199S1YWR
LISINOPRILLISINOPRILPD-Rx Pharmaceuticals, Inc.705582ed-da8c-418f-8bb2-fc0b74ed0a882026-10-15Boxed warning, Warnings, Adverse reactionsExact identifier
application number: ANDA076164
rxcui: 311353
unii: E7199S1YWR
LISINOPRILLISINOPRILSt. Mary's Medical Park Pharmacy5eff766f-82e2-4cd6-e053-2a91aa0a47822026-10-15Boxed warning, Warnings, Adverse reactionsExact identifier
application number: ANDA076164
rxcui: 197884
unii: E7199S1YWR
Lisinopril and HydrochlorothiazideLISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETSREMEDYREPACK INC.3bea11a3-eb07-46b2-9b91-f8a48a2f3b7e2026-10-12Boxed warning, Warnings, Adverse reactionsExact identifier
unii: E7199S1YWR
LisinoprilLISINOPRILBluePoint Laboratories34ebeea1-6812-4697-84c4-b2ae4f39e55f2026-10-07Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 314077
rxcui: 197884
rxcui: 205326
rxcui: 314076
rxcui: 311353
rxcui: 311354
unii: E7199S1YWR
LISINOPRILLISINOPRILSt. Mary's Medical Park Pharmacy6062fd98-7663-f4b5-e053-2a91aa0acbc32026-10-01Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 311354
unii: E7199S1YWR
Lisinopril and HydrochlorothiazideLISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETSSt. Mary's Medical Park Pharmacy00b266d9-ac4a-e931-e063-6294a90a6a0b2026-10-01Boxed warning, Warnings, Adverse reactionsExact identifier
unii: E7199S1YWR
Calamine Plus Pramoxine HClCALAMINE PLUS SPRAYTopco Associates LLCaf314adb-bd65-4233-b7e1-6cfb819615a32026-09-25WarningsExact identifier
unii: 1K09F3G675
Calamine Plus Pramoxine HClCALAMINE PLUS NO-TOUCHWalgreens Company33219878-f102-46c6-bd63-e83d54fa27852026-09-25WarningsExact identifier
unii: 1K09F3G675
CalamineCALAMINE, PRAMOXIND HCLNice-Pak Products, LLC9089e23e-ca4a-454f-8dcc-ff5a29a5a3352026-09-22Warnings, Adverse reactionsExact identifier
unii: 1K09F3G675
Lymph Tonic IIECHINACEA (ANGUSTIFOLIA), COLLINSONIA CANADENSIS, PHYTOLACCA DECANDRA, KALI IODATUM, PINUS SYLVESTRIS, PIX LIQUIDA, FERRUM PHOSPHORICUM, AESCULUS HIPPOCASTANUM, BARYTA CARBONICA, BERBERIS VULGARIS, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, CAUSTICUM, HEPAR SULPHURIS CALCAREUM, KREOSOTUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM MURIATICUM, NITRICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SILICEA, STELLARIA MEDIA, SULPHUR, TEREBINTHINA, THUJA OCCIDENTALIS, BUFO RANABioActive Nutritional, Inc.0e3265b0-b210-4a4c-80d2-8a9712981d4e2026-09-17WarningsExact identifier
unii: ETJ7Z6XBU4
CalamineCALAMINE, ZINC OXIDENice-Pak Products, LLCc370ee1f-1887-44e8-8d47-8ffa3c270ff52026-09-15Warnings, Adverse reactionsExact identifier
unii: 1K09F3G675

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.